nach oben

Erschienen in:

15.03.2017 | Original paper

Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses

verfasst von: Elizabeth M. Poole, Wayne T. Lin, Marina Kvaskoff, Immaculata De Vivo, Kathryn L. Terry, Stacey A. Missmer

Erschienen in: Cancer Causes & Control | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Endometriosis is associated with ovarian cancer, but the relation with endometrial cancer is unclear. Prior studies generally were retrospective and had potential limitations, including use of self-reported endometriosis, failure to account for delays between symptom onset and endometriosis diagnosis, and changes in risk factors post-endometriosis diagnosis. We evaluated whether these limitations obscured a weak association with endometrial cancer and the extent to which these limitations impacted associations with ovarian cancer.

Methods

Cox proportional hazards regression models were used to assess associations between endometriosis and cancer risk, evaluating the impacts of self-reported vs. laparoscopically confirmed endometriosis, delayed diagnosis, and post-endometriosis diagnosis changes in risk factor exposures on relative risk estimates.

Results

Over 18 years of follow-up, we identified 228 ovarian and 166 endometrial cancers among 102,025 and 97,109 eligible women, respectively. Self-reported endometriosis was associated with ovarian cancer [relative risk (RR): 1.81; 95% confidence interval (CI): 1.26–2.58]; this association was stronger for laparoscopically confirmed endometriosis (HR: 2.14; 95% CI 1.45–3.15). No association was observed with endometrial cancer (self-report RR: 0.78; 95% CI 0.42–1.44; laparoscopic-confirmation RR: 0.76; 95% CI 0.35–1.64). Accounting for diagnosis delays or post-endometriosis diagnosis changes in risk factors had a little impact.

Conclusions

This study adds to the evidence that endometriosis is not strongly linked to endometrial cancer risk and that the association with ovarian cancer is robust to misclassification, diagnostic delay, and changes in exposures post-endometriosis diagnosis. Our analysis suggests that confounding and misclassification do not obscure a weak association for endometrial cancer risk, although our results should be replicated.

Giudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362:2389–2398CrossRefPubMedPubMedCentral

Burney RO, Giudice LC (2012) Pathogenesis and pathophysiology of endometriosis. Fertil Steril 98:511–519CrossRefPubMed

Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ (2004) Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 160:784–796CrossRefPubMed

Brinton LA, Westhoff CL, Scoccia B et al (2005) Causes of infertility as predictors of subsequent cancer risk. Epidemiology 16:500–507CrossRefPubMed

Brinton LA, Sakoda LC, Sherman ME et al (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Int Soc Cell 14:2929–2935

Kobayashi H, Sumimoto K, Moniwa N et al (2007) Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 17:37–43CrossRefPubMed

Pearce CL, Templeman C, Rossing MA et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol 13:385–394CrossRefPubMedPubMedCentral

Buis CC, van Leeuwen FE, Mooij TM, Burger CW, Group OP (2013) Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 28:3358–3369CrossRefPubMed

Kvaskoff M, Mu F, Terry KL et al (2015) Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 21(4):500–516CrossRefPubMedPubMedCentral

10.

Lee WL, Chang WH, Wang KC et al (2015) The risk of epithelial ovarian cancer of women with endometriosis may be varied greatly if diagnostic criteria are different: a nationwide population-based cohort study. Medicine (Baltimore) 94:e1633CrossRef

11.

Mogensen JB, Kjaer SK, Mellemkjaer L, Jensen A (2016) Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol 143:87–92CrossRefPubMed

12.

de Boer EJ, den Tonkelaar I, Burger CW, van Leeuwen FE, Group OP (2005) Validity of self-reported causes of subfertility. Am J Epidemiol 161:978–986CrossRefPubMed

13.

Nnoaham KE, Hummelshoj L, Webster P et al (2011) Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 96(366–73):e8

14.

Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83:395–400CrossRefPubMed

15.

Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176:572–579CrossRefPubMed

16.

Melin A, Sparen P, Persson I, Bergqvist A (2006) Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 21:1237–1242CrossRefPubMed

17.

Munksgaard PS, Blaakaer J (2011) The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol 123:157–163CrossRefPubMed

18.

Rowlands IJ, Nagle CM, Spurdle AB, Webb PM, Australian National Endometrial Cancer Study G, Australian Ovarian Cancer Study G (2011) Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol 123: 537–541CrossRefPubMed

19.

Zucchetto A, Serraino D, Polesel J et al (2009) Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev Off J Eur Cancer Prev Organ 18:316–321CrossRef

20.

Kurman RJ, Shih Ie M (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol 42:918–931CrossRefPubMedPubMedCentral

21.

McConechy MK, Anglesio MS, Kalloger SE et al (2011) Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol 223:567–573CrossRefPubMed

22.

McConechy MK, Ding J, Senz J et al (2014) Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol 27:128–134CrossRefPubMed

23.

Rockhill B, Willett WC, Hunter DJ et al (1998) Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst 90:1155–1160CrossRefPubMed

24.

Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. Wiley, New York

25.

Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA (2002) Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer 94:1612–1618CrossRefPubMed

26.

Melin A, Sparen P, Bergqvist A (2007) The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 22:3021–3026CrossRefPubMed

27.

Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586–1590CrossRefPubMed

28.

Kim JJ, Kurita T, Bulun SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34:130–162CrossRefPubMedPubMedCentral

29.

Ness RB (2003) Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 189:280–294CrossRefPubMed

30.

Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C (2008) The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 90:1559–1570CrossRefPubMed

31.

Maccio A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58:133–147CrossRefPubMed

32.

Lee AW, Templeman C, Stram DA et al (2015) Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril 105(1):35–43CrossRefPubMedPubMedCentral

33.

Lu Y, Cuellar-Partida G, Painter JN et al (2015) Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet 24:5955–5964CrossRefPubMedPubMedCentral

34.

Sato N, Tsunoda H, Nishida M et al (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052–7056PubMed

35.

Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11:63–70CrossRefPubMed

36.

Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363:1532–1543CrossRefPubMedPubMedCentral

37.

Holt VL, Weiss NS (2000) Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology 11:654–659CrossRefPubMed

38.

Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21:1851–1856CrossRefPubMedPubMedCentral

39.

Brasky TM, Felix AS, Cohn DE et al (2017) Nonsteroidal anti-inflammatory drugs and endometrial carcinoma mortality and recurrence. J Natl Cancer Inst 109(3):djw251. doi:10.1093/jnci/djw251

40.

Brinton LA, Felix AS, McMeekin DS et al (2013) Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 129:277–284CrossRefPubMedPubMedCentral

41.

Brinton LA, Trabert B, Anderson GL et al (2016) Serum estrogens and estrogen metabolites and endometrial cancer risk among postmenopausal women. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Int Soc Cell 25:1081–1089

42.

Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607–2618CrossRefPubMedPubMedCentral

43.

Uccella S, Mariani A, Wang AH et al (2013) Intake of coffee, caffeine and other methylxanthines and risk of type I vs type II endometrial cancer. Br J Cancer 109:1908–1913CrossRefPubMedPubMedCentral

Titel: Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses
verfasst von: Elizabeth M. Poole
Wayne T. Lin
Marina Kvaskoff
Immaculata De Vivo
Kathryn L. Terry
Stacey A. Missmer
Publikationsdatum: 15.03.2017
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 5/2017
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-017-0856-4

Springer Medizin

Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses